Not so long ago,
human embryonic stem cell (hESC)
research and SCNT were being hailed as the
future of regenerative medicine, capable
of generating cures and therapies for any number
of diseases and conditions.
Last week, a ruling by federal Judge Royce C. Lamberth left many
human embryonic stem cell (hESC) researchers not only scrambling for funding and concerned about the
future of their own
research, but also concerned for the
future of the whole field in this country.